The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Mike Sanders, Chief Executive Officer at Vital Hub UK Group of Companies, explains the importance of delivering sustainable solutions for healthcare in support of the whole patient journey beyond COVID-19.
Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".
Sarah-Jane McQueen, General Manager of the online healthcare course comparison website at CoursesOnline explains how health workers can find the time to focus on their learning & development in this special skills focus.
European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.
Assistant Professor Rachel Brulé, Global Development Policy at Boston University, says that COVID exposed existing inequalities and explains why gender inclusive institutions can help.
According to a new analysis by researchers, ethnic minorities in the US experienced disproportionately high levels of cardiac deaths during the pandemic - in comparison to the rates in 2019.
The team examined a mix of factors such as pollution, crime, access to education and healthcare - they found that in over 7,000 children, these factors directly impacted brain development.
The REACT study suggests that scientists don't know if the Indian variant is more infectious than the Kent variant - largely responsible for the winter wave of deaths.
Oliver Brown, Head of Product, Care and Support Tools at Imosphere, explores how financial pressures and a lack of certainty over adult social care funding is a problem for local authorities and the need to bring reform to an already stretched system.
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.
Scientists examining how COVID impacts the entire human body, not just the lungs, believe that there could be a link between the endothelium and Long COVID.
Sarah MacFadyen, Vice Chair of the Taskforce for Lung Health and Head of Policy and External Affairs at Asthma UK and the British Lung Foundation, says it’s time that tobacco dependency was treated just like any other illness.
